Lori J Braender's most recent trade in Aquestive Therapeutics Inc was a trade of 110,000 Common Stock done . Disclosure was reported to the exchange on March 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Lori J. Braender | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 110,000 | 423,231 (1%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Lori J. Braender | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 60,000 | 60,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Lori J. Braender | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 10,658 | 402,981 (1%) | 0% | 2.7 | 28,244 | Common Stock |
| Aquestive Therapeutics Inc | Lori J. Braender | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 9,592 | 413,639 (1%) | 0% | 2.7 | 25,419 | Common Stock |
| Aquestive Therapeutics Inc | Lori J. Braender | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 10,530 | 313,231 (0%) | 0% | 4.9 | 51,386 | Common Stock |
| Aquestive Therapeutics Inc | Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 135,000 | 323,761 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 67,500 | 67,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 75,000 | 75,000 | - | - | Performance Stock Units | |
| Aquestive Therapeutics Inc | Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 75,000 | 75,000 | - | - | Performance Stock Units | |
| Aquestive Therapeutics Inc | Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 150,000 | 188,761 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 40,000 | 40,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Lori J. Braender | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jun 2022 | 13,761 | 38,761 (0%) | 0% | 1.0 | 13,211 | Common Stock |
| Aquestive Therapeutics Inc | Lori J. Braender | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Jun 2022 | 13,761 | 13,761 | - | - | Warrant (Right to Buy) | |
| Aquestive Therapeutics Inc | Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 160,000 | 160,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 75,000 | 75,000 | - | - | Non-Qualified Stock Option (right to buy) |